Radiation Oncology/Therapy: Page 293

Prostate brachytherapy side effects self-resolve
By AuntMinnie.com staff writers
Most men who have permanent prostate brachytherapy treatment for early-stage prostate cancer experience urinary side effects, but symptoms resolve for the majority of patients within one year following completion of radiation treatment, according to a report published in the September issue of Urology.
September 10, 2009
Algeta, Bayer join forces
By AuntMinnie.com staff writers
Therapeutic radiopharmaceutical developer Algeta has inked an $800 million agreement with Bayer for the development and commercialization of its Alpharadin alpha-emitting pharmaceutical for treating bone metastases.
September 7, 2009
Still River taps Jachinowski as new CEO
By AuntMinnie.com staff writers
Proton radiotherapy vendor Still River Systems has tapped veteran radiation therapy executive Joseph Jachinowski as its new CEO.
September 7, 2009
Elekta takes Czech software order
By AuntMinnie.com staff writers
Swedish oncology firm Elekta will provide treatment planning and information management software for Proton Therapy Center Czech.
September 3, 2009
Nucletron reports 6-month 2009 results
By AuntMinnie.com staff writers
Radiation oncology firm Nucletron enjoyed strong financial results over the first half of 2009.
September 2, 2009
Elekta taps new North American head
By AuntMinnie.com staff writers
Swedish oncology firm Elekta has appointed James Hoey as CEO of its North American organization.
September 2, 2009
IGRT boosts outcomes for obese prostate cancer patients
By AuntMinnie.com staff writers
Image-guided radiation therapy (IGRT) may yield improved outcomes for moderately to severely obese prostate cancer patients, according to a study published in the September 1 issue of the International Journal of Radiation Oncology, Biology, Physics.
September 2, 2009
Resonant to unveil new Clarity version
By AuntMinnie.com staff writers
Ultrasound image-guided radiation therapy (IGRT) developer Resonant Medical will showcase the next generation of its Clarity IGRT system at next week's European Society for Therapeutic Radiology and Oncology annual meeting.
September 1, 2009
FDA OKs Hologic's MammoSite ML
By AuntMinnie.com staff writers
Women's imaging vendor Hologic has received 510(k) clearance from the U.S. Food and Drug Administration for the company's MammoSite ML breast brachytherapy system.
September 1, 2009
Higher urethral dose means more toxicity when treating prostate cancer
By Cynthia E. Keen
There's a direct relationship between radiation dose to the urethra and genitourinary toxicity in prostate cancer patients who receive both high-dose-rate brachytherapy and hypofractionated external-beam radiation therapy, Japanese researchers report in the International Journal of Radiation Oncology, Biology, Physics.
August 31, 2009
Varian debuts Unique for global markets
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems has introduced a new low-energy radiation therapy system for international cancer clinics at this week's European Society for Therapeutic Radiology and Oncology conference in Maastricht, Netherlands.
August 30, 2009
Tomotherapy changes appearance of lung inflammation on CT
By Cynthia E. Keen
Patients undergoing tomotherapy procedures may exhibit signs of post-treatment lung inflammation that differ from those found with more traditional forms of radiation therapy -- a phenomenon that radiologists should be aware of when following up patients, according to South Korean researchers.
August 30, 2009
2009 08 28 13 41 05 459 09 08 2298 04b Thumb
Previous Page
Page 293 of 464
Next Page